As of 2025-09-15, the Relative Valuation of Atea Pharmaceuticals Inc (AVIR) is (34.22) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.14 USD, the upside of Atea Pharmaceuticals Inc based on Relative Valuation is -1189.8%.
The range of the Relative Valuation is (32.73) - (35.03) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.7x - 20.4x | 18.9x |
| Forward P/E multiples | 19.1x - 21.6x | 21.0x |
| Fair Price | (32.73) - (35.03) | (34.22) |
| Upside | -1142.3% - -1215.5% | -1189.8% |
| Date | P/E |
| 2025-09-08 | -1.89 |
| 2025-09-05 | -1.96 |
| 2025-09-04 | -1.94 |
| 2025-09-03 | -2.02 |
| 2025-09-02 | -1.98 |
| 2025-08-29 | -1.96 |
| 2025-08-28 | -2.02 |
| 2025-08-27 | -2.10 |
| 2025-08-26 | -2.13 |
| 2025-08-25 | -2.13 |
| 2025-08-22 | -2.13 |
| 2025-08-21 | -2.06 |
| 2025-08-20 | -2.04 |
| 2025-08-19 | -2.03 |
| 2025-08-18 | -2.06 |
| 2025-08-15 | -2.04 |
| 2025-08-14 | -2.03 |
| 2025-08-13 | -2.04 |
| 2025-08-12 | -2.05 |
| 2025-08-11 | -2.05 |
| 2025-08-08 | -1.97 |
| 2025-08-07 | -2.02 |
| 2025-08-06 | -2.03 |
| 2025-08-05 | -2.05 |
| 2025-08-04 | -2.06 |
| 2025-08-01 | -2.02 |
| 2025-07-31 | -2.12 |
| 2025-07-30 | -2.14 |
| 2025-07-29 | -2.22 |
| 2025-07-28 | -2.21 |
| 2025-07-25 | -2.27 |
| 2025-07-24 | -2.18 |
| 2025-07-23 | -2.03 |
| 2025-07-22 | -2.00 |
| 2025-07-21 | -2.00 |
| 2025-07-18 | -1.96 |
| 2025-07-17 | -2.02 |
| 2025-07-16 | -2.03 |
| 2025-07-15 | -2.08 |
| 2025-07-14 | -2.19 |
| 2025-07-11 | -2.14 |
| 2025-07-10 | -2.20 |
| 2025-07-09 | -2.19 |
| 2025-07-08 | -2.13 |
| 2025-07-07 | -2.12 |
| 2025-07-03 | -2.18 |
| 2025-07-02 | -2.11 |
| 2025-07-01 | -2.10 |
| 2025-06-30 | -2.10 |
| 2025-06-27 | -2.01 |